Get started
Author

Viktoryia Laurynenka

Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus
2020 · Xianyong Yin, Kwangwoo Kim, et al. · Annals of the Rheumatic Diseases · 175
PDF
The 330 risk loci known for systemic lupus erythematosus (SLE): a review
2024 · Viktoryia Laurynenka, John B. Harley · Frontiers in Lupus · 45
A High Prevalence of Anti-EBNA1 Heteroantibodies in Systemic Lupus Erythematosus (SLE) Supports Anti-EBNA1 as an Origin for SLE Autoantibodies
2022 · Viktoryia Laurynenka, Lili Ding, et al. · Frontiers in Immunology · 41
1502 Genetic predisposition to lupus across ancestries has >300 separable genetic contributions: what we know today
2021 · Viktoryia Laurynenka, Leah C Kottyan, et al. · Lupus Science & Medicine · 2
PDF
702 Comparative genome wide association studies (GWASs) of systemic lupus erythematosus (SLE) and multiple sclerosis (MS) from the million veteran program (MVP)
2024 · Viktoryia Laurynenka, Dennis H Clark, et al. · Lupus Science & Medicine · 1
1401 A Genome Wide Association Scan of SLE genetic risk in a cohort of African-American persons
2022 · Isaac TW Harley, Celi Sun, et al. · Lupus Science & Medicine · 1
PDF
1706 A model of lupus pathogenesis: anti-EBNA1 heteroantibodies initiate lupus by cross reacting with lupus autoantigens, resulting in lupus autoantibodies and clinical disease
2021 · Viktoryia Laurynenka, Lili Ding, et al. · Lupus Science & Medicine · 1
PDF
The Ikaros1, IKZF1, risk locus for Acute Lymphoblastic Leukemia (ALL) at chromosome 7p12.2 regulates the expression of the FIGNL1 gene
2020 · Viktoryia Laurynenka, Danielle Ho, et al. · The Journal of Immunology · 1
P136 Epstein-barr Virus Transcription Co-factors Bind to Many Inflammatory Bowel Disease Risk Loci
2020 · Batool Emadi, Martha Carter, et al. · Inflammatory Bowel Diseases · 1
New role of Epstein-Barr virus in pathogenesis of acute and chronic lymphocytic leukemia
2019 · Viktoryia Laurynenka, Martha Carter, et al. · The Journal of Immunology · 1
Enhanced EBNA2-dependent activity in EBV-transformed B cells from patients with multiple sclerosis
2026 · Marissa Granitto, Ellie Kim, et al. · medRxiv
PDF
701 A million veteran program (MVP) genome-wide association study (GWAS) of systemic and cutaneous lupus erythematosus (SLE & CLE)
2024 · Dennis H Clark, Isaac TW Harley, et al. · Lupus Science & Medicine
502 The epigenetics of the now known 330 lupus genetic risk loci in two ancestries are independently consonant with causal regulatory mechanisms involving epstein-barr virus (EBV)-encoded transcription co-factors expressed in EBV-infected, EBV latency III-expressing B cells (LCLs)
2024 · Viktoryia Laurynenka, Xiaoting Chen, et al. · Lupus Science & Medicine
LP-114 Lupus and multiple sclerosis may share an initiating pathogenesis: the anti- EBNA1 heuristic conjecture
2023 · John B Harley, Dennis H Clark, et al. · Lupus Science & Medicine
PDF
Latency III gene products of Epstein-Barr Virus (EBV) are associated with Systemic Lupus Erythematosus (SLE) genetic risk loci
2020 · Viktoryia Laurynenka, Xiaoting Chen, et al. · The Journal of Immunology
P136 Epstein-barr Virus Transcription Co-factors Bind to Many Inflammatory Bowel Disease Risk Loci
2020 · Batool Emadi, Martha Carter, et al. · Gastroenterology
Works count: 16
Citation count: 269
H-index: 3
I10-index: 3
Year
Topic
Type